跳至主要内容
临床试验/NCT03991637
NCT03991637已完成不适用

Remote Sensing Comprehensive Metabolic Panel

Joseph Allen Jr.1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年7月18日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Performance of Non-Invasive Comprehensive Metabolic Panel

研究概览

简要总结

The study considers a cross-validation approach to determine the effectiveness of a non-invasive comprehensive metabolic panel (NICMP), relative to the venipuncture method. The NICMP machine learned powered device utilizes a light sensor to capture readings from either palm. The study (n=90) proves an agreement and strong correlation with respect to the NICMP and venipuncture blood draw.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Undiagnosed population

排除标准

  • •Diagnosed population, pregnant women, mental heath/disabled, prisoners, fetus or deceased

研究组 & 干预措施

NICMP Spectral Reading

Experimental

Non-invasive spectral data is collected from this arm to function as the intervention of interest.

干预措施: Non-Invasive Comprehensive Metabolic Panel (Device)

Venipuncture CMP

Active Comparator

A standard CMP blood draw is performed to function as the "gold standard" reference value.

Specifically, the outcome of the experimental arm is cross-validated against the active comparator arm to determine the NICMP accuracy, relative to the venipuncture method.

干预措施: Non-Invasive Comprehensive Metabolic Panel (Device)

结局指标

主要结局

Performance of Non-Invasive Comprehensive Metabolic Panel

时间窗: 2-minutes

Determine the effectiveness, in terms of accuracy, of the NICMP against the venipuncture CMP (i.e. reference value).

次要结局

未报告次要终点

研究者

发起方
Joseph Allen Jr.
申办方类型
Industry
责任方
Sponsor Investigator
主要研究者

Joseph Allen Jr.

Chief Executive Officer/Biomedical Engineer

Concord Medical Technology Corporation

研究点 (1)

Loading locations...

相似试验

已完成
不适用
An Observational Study On Metabolic Syndrome Parameters In Schizophrenia Patients Treated With Atypical AntipsychoticsMetabolic Syndrome XSchizophrenia
NCT00448630Pfizer's Upjohn has merged with Mylan to form Viatris Inc.328
已完成
不适用
Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of MetabolismCongenital Disorders of Glycosylation
NCT04201067Mayo Clinic240
已完成
不适用
Clinical Validation of Continuous and Non-invasive Monitoring of Effective Pulmonary Volume.Critical Illness
NCT04045262Fernando Suarez Sipmann85
进行中(未招募)
1 期
Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trialesophageal ADC, esophageal SCC, Cholangiocarcinoma, urothelial cancer (progressive after immunotherapy), or endometrial cancerMedDRA version: 20.0Level: LLTClassification code 10055458Term: Esophageal adenocarcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10055476Term: Esophageal squamous cell carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10008595Term: Cholangiocarcinoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10014735Term: Endometrial cancer NOSSystem Organ Class: 100000004864
EUCTR2017-000123-28-FRInstitut Jules Bordet185
进行中(未招募)
1 期
Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trialesophageal ADC, esophageal SCC, Cholangiocarcinoma, urothelial cancer (progressive after immunotherapy), or endometrial cancerMedDRA version: 20.0Level: LLTClassification code 10055458Term: Esophageal adenocarcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10055476Term: Esophageal squamous cell carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10008595Term: Cholangiocarcinoma NOSSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 100000004864MedDRA version: 20.0Level: LLTClassification code 10014735Term: Endometrial cancer NOSSystem Organ Class: 100000004864
EUCTR2017-000123-28-BEInstitut Jules Bordet185
Non-Invasive Blood Test Cross-Validation Study | 临床试验